Board MeetingMay 20, 2026, 08:02 AM
Absci to Present at Jefferies and Goldman Sachs Conferences
AI Summary
Absci Corporation announced its participation in two upcoming investor conferences in June 2026. The company will present at the Jefferies Global Healthcare Conference on June 3rd and the Goldman Sachs 47th Annual Global Healthcare Conference on June 9th. Webcasts of these presentations will be accessible via Absci's investor relations website. Absci is a clinical-stage biopharmaceutical company leveraging generative AI for drug discovery and advancing its own therapeutic pipeline.
Key Highlights
- Absci will present at the 2026 Jefferies Global Healthcare Conference on June 3rd at 7:35 a.m. ET.
- Absci will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9th at 3:20 p.m. ET.
- Live and archived webcasts of the presentations will be available on Absci's investor relations website.
- Absci is a clinical-stage biopharmaceutical company using generative AI for drug discovery.
- The company is advancing its own pipeline, including ABS-201 for hair regrowth and endometriosis.
Price Impact
More from ABSI